SGEN
Seagen Inc.
214.29
USD
This page is just a preview of the data found in TrendSpider’s full version
Seagen Inc. stock is up 0.07% since 30 days ago. The next earnings date is Feb 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60.87% of the previous 22 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 10 PUTs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 24 Nov 17:18 | 15 Dec, 2023 | 210.00 | 10515 | ||
| 27 Nov 15:04 | 19 Jan, 2024 | 210.00 | 43401 | ||
| 27 Nov 15:14 | 17 Jan, 2025 | 210.00 | 414 | ||
| 27 Nov 15:19 | 17 Jan, 2025 | 210.00 | 414 | ||
| 27 Nov 15:58 | 17 Jan, 2025 | 210.00 | 414 | ||
| 27 Nov 17:48 | 17 Jan, 2025 | 210.00 | 414 | ||
| 28 Nov 16:28 | 15 Dec, 2023 | 210.00 | 10145 | ||
| 28 Nov 18:50 | 19 Jan, 2024 | 210.00 | 43545 | ||
| 28 Nov 20:14 | 15 Dec, 2023 | 210.00 | 10145 | ||
| 28 Nov 20:15 | 21 Jun, 2024 | 220.00 | 64156 |
Seagen Inc. develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate, PADCEV, and TUKYSA. It also develops TIVDAK for metastatic cervical cancer and other solid tumors.
